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Summary 
A series of immunoglobulin (Ig)-transgenic mice were generated to study the functional capabilities 
of the IgM and IgD dasses orb lymphocyte antigen receptor in regulating both cellular devdopment 
and responses to specific  antigen. B cells from Ig-transgenic mice expressing either hen-egg lysozyme 
(HEL)-specific IgM or IgD alone were compared with B cells from mice that coexpressed IgM 
and IgD of the same anti-HEL specificity. In all three types of Ig-transgenic mice, conventional 
B cells specific for HEL exhibited exclusion of endogenous Ig expression and matured to populate 
the usual microenvironments in peripheral lymphoid tissues. These peripheral B cells could be 
stimulated by HEL through either IgM or IgD antigen receptors to generate T cell dependent 
antibody  production  in  vivo  or  to  enhance  T  cell  independent proliferative  responses  to 
lipopolysaccharide in vitro. Conversely, when HEL was encountered in vivo as a self-antigen, 
B cells expressing HEL-specific IgM or IgD alone were both rendered tolerant. In each case this 
occurred by clonal anergy in response to soluble autologous HEL, and clonal deletion when 
HEL was recognized as a membrane-bound self-antigen. Taken together, these findings indicate 
that IgM and IgD antigen receptors expressed alone on conventional B cells can support normal 
differentiation, antigen-dependent activation, and induction of self-tolerance,  the only overt difference 
lying in a greater degree of receptor downregulation for IgM relative to IgD after induction 
of clonal anergy by soluble HEL. 
T 
he various classes of Ig produced by mammalian B lym- 
phocytes  have the dual function of serving  as surface 
receptors for antigen and as effector molecules secreted in re- 
sponse to antigenic stimulation. Whereas distinct effector roles 
appear to account for the existence of IgM, IgG, IgA, and 
IgE, a unique function for IgD has remained obscure. Al- 
though little secreted IgD can be detected (1, 2), cell-surface 
IgD is coexpressed with IgM on the majority of mature B 
cells in peripheral lymphoid tissues of mice and humans (3-5). 
IgM and IgD molecules present on individual B cells share 
identical V regions and antigen binding sites (6-8), and are 
coexpressed by differential splicing of a common VDJ exon 
to either C/z or C~ C region exons after transcription of the 
V.-/~-/~ locus in the cell's functionally rearranged Ig H chain 
gene (9). Despite the fact that IgD is an abundant receptor 
on most B cells found in follicular mantle zones of lymphoid 
tissues and in peripheral blood, its expression appears to be 
restricted to this single stage during B cell development. Thus, 
only/z H  chains are synthesized in pre-B cells, and IgM is 
expressed without IgD on the surface of newly differentiated, 
immature B cells in the bone marrow (7, 10, 11). Similarly, 
IgD is expressed  at  only very low levels on the IgM~g  h 
B cells in the splenic marginal zone (12) and on IgM~  h cells 
belonging to the B1 (Ly-1/CD5) B cell lineage (13, 14), and 
is  absent  from high affinity  memory B  cells which have 
switched to  expression  of downstream H  chain isotypes 
(15, 16). 
The characteristic pattern of expression exhibited by IgD 
has focused attention on the possibility that this class of an- 
tigen receptor may have signaling properties  distinct from 
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coexpressing IgM and IgD relative to those bearing IgM alone. 
In particular,  previous evidence supported unique roles for 
IgM and IgD in determining whether B cell tolerance or ac- 
tivation occurred, since antigen binding to IgM alone on im- 
mature IgD- B cells induced tolerance, whereas binding of 
antigen  by mature  B  cells generally  provided  stimulatory 
signals (for review see reference 17).  Consistent with these 
findings, more recent studies of immature B cell lymphomas 
expressing IgD after transfection have shown that antibody- 
mediated crosslinkage of membrane IgD is incapable of in- 
ducing the growth-arrest normally observed after IgM cross- 
linkage  (18,  19).  By contrast,  the  IgM  and  IgD  antigen 
receptors on B cells have appeared functionally similar in one 
study of lymphoma growth arrest (20) and in many studies 
of antigen  presentation  and  T  cell  dependent  activation 
(21-25),  T  cell independent  activation (26), and elicitation 
of intracellular  second messages (27,  28). 
To date,  much of the information  on class-specific  func- 
tions of IgM and IgD antigen receptors has been obtained 
using anti-p and -/~ chain antibodies to simulate the binding 
of antigen. Extrapolation of these results to responses induced 
by bona fide antigens,  however, is complicated by the fact 
that isotype-specific antibodies do not interact with the normal 
antigen  binding  site of membrane  Ig,  and that  the conse- 
quences of their interactions with the receptor may therefore 
be dependent on the site, affinity, or avidity of binding rather 
than isotype specificity per se (29-31). As an alternative ap- 
proach to studying the functions of IgM and IgD antigen 
receptors, we have produced two parallel sets of Ig-transgenic 
mice in which most B cells express either transgene-encoded 
IgM or IgD alone, each possessing identical  specificity for 
the  well-characterized  protein  antigen,  hen-egg  lysozyme 
(HEL) 1. Consequently,  the development and responsiveness 
of IgM-only or IgD-only HEbspecific B cells could be fol- 
lowed in vivo either in the absence of immunization,  after 
challenge with HEL as an immunogenic foreign antigen, or 
after encounter with HEL as a soluble or membrane-bound 
self-antigen.  Assayed  in  this  way,  IgM  and  IgD  antigen 
receptors were indistinguishable with respect to exclusion of 
endogenous Ig expression, promotion of B cell maturation, 
and in the signaling of B cell activation, anergy, and deletion. 
Materials and Methods 
M~c~  Conventional inbred C57BL/6 and CBA mice, (C57BL/6 
xCBA)F1 mice, and transgenic mouse lines were maintained  in 
the Blackburn Animal Facility, University of Sydney. Hemizygous 
Ig-transgenic and HEIctransgenic mouse lines were maintained on 
a C57BL/6 background  by backcrosses with nontransgenic  and 
transgenic C57BL/6 mice. 
Gene Constructs.  The original MD (IgM +  IgD) series of Ig- 
transgenic mice was produced by cointroducing  H chain (V.10- 
1 Abbreviations used in thist~per: HEL, hen-egg lysozyme;  HSA, heat stable 
antigen. 
#-~) and L chain (V,10-C~) Ig gene constructs into the germline 
of C57BL/6 (H chain b-allotype,  IgH  8) mice (32). These con- 
strncts together encode IgM and IgD (H chain a-allotype, IgH  ~) 
carrying the antigen binding  site of the high-affinity (1.5  x  109 
M-l) anti-HEL  mAb HyHEL10 (33, 34). The V.10-/~ H chain 
gene construct  comprising the HyHEL10 VDJ segment and # H 
chain sequences was assembled in the EcoRI site of the pSVG-gpt 
vector during production of the pSVG-V.10-#-/~ plasmid (32). The 
pSVG-V.10-6 plasmid was produced by partial EcoRI digestion of 
pSVG-V.10-p-6 to remove the 12.4-kb EcoRI fragment containing 
the/~ H chain switch recombination and C region coding sequences 
(Fig. 1). Construction of V~10-C, has been described previously 
(32), All these gene constructs were prepmx~d using standard recom- 
binant  DNA techniques (35). 
Transgenic Lines.  For microinjection, gene constructs were sepa- 
rated from vector sequences by digestion  with SalI and purified 
as described (32). MM (V.10-p  +  V~10-C~) and DD (V.10-/~ + 
V~10-C~) founder Ig-transgenic mice were generated after microin- 
jection of C57BL/6 fertilized eggs with an equimolar mixture of 
H and L chain constructs as described (32, 36). Screening for founder 
Ig-transgenic  mice and their progeny was performed initially by 
Southern blot analysis of tail DNA (36), but subsequently by ELISAs 
detecting  serum anti-HEL  IgM  ' or anti-HEL  IgD  a (see below). 
Southern blot analyses revealed the approximate numbers of trans- 
gene copies in the Ig-transgenic lines used in this study to be: MD-4 
=  6-8 p6, 4-6 K; MM-4 =  4-6 #, 2-3 K; MM-7 =  3-5 #, 3-5 
K; DD-1  =  6-8 ~, 2-3 K, and DD-6  =  2-3 ~, 3-5 K. 
Transgenic  mice  expressing  soluble  HEL  (MIr  line) or 
membrane-bound  HEL (KLK-3 line) (32, 37) were screened sero- 
logically using a HEL-specific  ELBA (see below). Double-transgenic 
mice inheriting  Ig and soluble-HEL transgenes were produced by 
crossing Ig-transgenic and ML-5 HEL,  transgenic mice, or by mating 
existing double-transgenic with nontransgenic mice. Progeny were 
screened by serum ELISAs detecting HEL and either IgM  ~, anti- 
HEL  IgM  ~,  or  anti-HEL  IgD ~ (see below).  Ig-transgenic  and 
double-transgenic  mice were analyzed when aged 5-15 wk. 
mAbs.  The following mAbs were used (specificities  bracketed): 
RS-3.1 (IgMa; 38); AMS-15.1 (IgD'; 39); AF6-78.25 (IgMb; 39); 
RA3-6B2 (B220; 40); M1-69 (heat stable antigen [HSA]; 41); 53-7 
(CDS; 42); HyHEL5 (HEL; 43); and HyHEL10 (HEL; 33). Purified 
antibodies were labeled with biotin or fluorescein as previously in- 
dicated (32). Biotinylated 53-7 was purchased from Becton Dick- 
inson  Immunocytometric  Systems (Mountain  View, CA)  and 
PE-labeled RA3-6B2 from Caltag Laboratories (South San Fran- 
cisco, CA). 
FACS  |  Analysis.  Spleen,  lymph node, and bone marrow cells 
were prepared and stained for FACS  |  analysis as previously indi- 
cated (32). For two-color analysis, cells were incubated with both 
directly  fluoresceinated and  directly  biotinylated  reagents,  and 
binding  of biotin-labeled reagents revealed with streptavidin/PE 
(Caltag Laboratories). HEL binding was detected with 200 ng/ml 
HEL followed by biotinyhted HyHEL5 (32), or with HEL/fluores- 
cein. For three-color analysis, staining by biotinylated  antibodies 
was revealed with streptavidin/RED613  (Gibco BILL, Gaithers- 
burg, MD). Fluorescence and light scatter data from stained cells 
were acquired on either a FACS  |  440 or FACScan  |  flow cytometer 
(Becton Dickinson & Co.), and data from calls exhibiting  a lym- 
phocyte scatter profile displayed. FACS  ~ 440 fluorescence data were 
displayed in two-dimensional  contour plots  (32), and FACScan  | 
fluorescence data were displayed in two-dimensional  dot plots. 
ELISAs.  The ELISA for detecting  anti-HEL  IgM  a was per- 
formed using HEL-coated microtitre  plates as described (44), and 
modified to detect anti-HEL  IgD  ~ using biotinylated  AMS-15.1. 
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a  hybridoma  secreting  transgene-encoded  anti-HEL  IgM'  (J. 
Crosbie, unpublished  data) and from transfected Sp2/0 myeloma 
cells  secreting  transgene-encoded  anti-HEL  IgD'.  ELISAs de- 
tecting  serum HEL and total IgM' were performed  as described 
(33, 44). 
Irnraunohistology.  Mouse spleens were prepared and stained as 
described (45). 
Adoptive Transfer.  Spleen  cells were prepared from Ig-transgenic 
and double-transgenic donors and from 2-6-mo-old nontransgenic 
C57BL/6 male mice primed with 2  x  10  s SRBC intraperitoneaUy 
1-4 mo earlier. HEL was covalently coupled to SRBC as previ- 
ously indicated (32), while control SRBC were mock-labeled in 
the absence of HEL. 3-6-too-old nontransgenic  C57BL/6 male 
recipients irradiated with 750 tad were injected intravenously with 
a single inoculum containing  104 Ig-transgenic  or double-trans- 
genic spleen cells, 5  x  10  ~ SRBC-primed spleen cells, and 2  x 
10  s HEDSRBC or control SRBC. Recipients were bled 7 d after 
cell  transfer  and  serum  levels of anti-HEL  IgH  '  measured  by 
ELISA (see above). 
In Vitro Stimulation with LPS.  Spleen  cells were cultured with 
LPS (20 ~tg/ml)  +  HEL (100 ng/ml) and [3H]thymidine incor- 
poration  was measured after 64 h as described (46). 
Bone Marrow Chimeras.  Nontransgenic (C57BL/6) and KLK-3 
membrane-HEL  transgenic recipients aged between 4 and 10 mo 
were irradiated  with  950  tad  and  injected  intravenously  with 
3  x  106 bone marrow cells from Ig-transgenic donors. Chimeras 
were allowed to reconstitute  for 6 wk before analysis. 
Results 
Producti, n of lgM-only and IgD-only Anti-HEL Ig-transgenic 
Mice.  To generate transgenic mice with B cells expressing 
anti-HEL IgM or IgD alone,  the V.10-/z-/~ construct used 
to  produce  the  original  MD  (IgM  +  IgD)  series  of Ig- 
transgenic mice (32) was modified to yidd two different H 
chain  constructs,  V.10-#  and  V.10-/i  (Fig.  1).  Although 
both V.10-# and V.10-/i retained  the same transcriptional 
control dements  and VDJ exon,  in V.10-/z  the/z-/~  locus 
was truncated Y to the C/z constant region exons to exclude 
the C/$ exons and eliminate  the possibility of IgD expres- 
sion. In V.10-r  an internal deletion was made from V,10- 
#-8 that removed the C/z exons and placed the C/~ exons im- 
mediately downstream of the VDJ region, analogous to the 
arrangement  of the Ig H  chain gene in IgD-secreting plas- 
macytomas (47).  Coinjection of the V~10-C~ L chain con- 
struct  (32) into  C57BL/6 embryos with either V,10-/~ or 
V,10-/~ yielded eight/~  +  K (MM) and four ~  +  g (DD) 
founder  Ig-transgenic  mice carrying  multiple  cointegrated 
copies of H and L chain gene constructs. In the current paper, 
four representative Ig-transgenic lines (MM-4, MM-7, DD-1, 
and  DD-6)  derived  from  founder  mice  that  carried  low 
numbers of transgene copies (see Materials and Methods) were 
selected for study and analyzed in conjunction with the pre- 
viously characterized  MD-4 Ig-transgenic  line (45). 
Ig Expression  by Ig-transgenic Mice.  Expression of the Ig 
transgenes was monitored by ELISA and FACS  |  analysis that 
detected both transgene-encoded H  chain (a-allotype, IgH') 
and antigen specificity (HEL-binding).  In lymphoid tissues 
of the representative Ig-transgenic lines,  cell surface expres- 
sion of IgH  a was confined to cells of the B lineage as judged 
by coexpression of the B220 isoform of CD45  (40)  (Figs. 
2 and 9 A). The great majority of mature splenic B cells in 
MM  and DD  Ig-transgenic  mice expressed high  levels  of 
IgMa and IgD  ', respectively,  but no detectable IgM carrying 
endogenous (C57BL/6) b-allotype/z chain (IgM  b) (Fig.  3). 
This is consistent with previous findings that rearranged/~ 
as well as/~ H chain transgenes inhibit expression of endoge- 
nous H  chain genes (48-50).  The small numbers of B cells 
that  did  express  IgM  b stained  very weakly for  transgene- 
encoded IgH  '  (Fig.  3), which suggests that these cells may 
express the Ig transgenes at low levels. Alternatively, this ob- 
servation is consistent with cytophilic binding of transgene- 
derived Ig since similar levels of IgH  ' staining are found on 
IgH  b+ cells (and vice versa)  in nontransgenic (C57BL/6  x 
CBA)FI animals  (Fig.  3). 
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Figure 1.  Structure  of Ig H chain gene constructs. 
MD Ig-transgenic mice in which B cells coexpressed 
anti-HEL IgM and IgD had been  produced  previously 
(32) using the V.10-~-~ H  chain construct (top). 
V.10-# (bottom left) and V.10-8 (bottom right) H chain 
constructs were derived from V.10-/~-~ and microin- 
jected to produce  MM and DD Ig-transgenic mice ex- 
pressing anti-HEL IgM or anti-HEL IgD alone. (Thin 
open bars) Flanking or intronic DNA sequences; (in. 
termediate  open bars) 5' and 3' untranslated sequences; 
(thick open bars) coding sequences. Exons encoding the 
constant domains (C) and membrane termini (M) of 
the tt and 8 H chains are indicated, as are those en- 
coding the secretory  terminus (S) and potential secre- 
tory terminus (X) (9) of the 8 chain. The rearranged 
VDJ exon of the HyHEL10 hybridoma and the ac- 
companying  leader (L) sequence  are also included. (Thin 
striped bar) Switch recombination sequences of the t~ 
H chain gene (St), (thin black bar 3' of the VDJ exon) 
H chain enhancer element. Restriction endonuclease 
recognition sites are indicated for EcolLl (R), BamHI 
(B), and SalI (S). 
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Figure 2.  Expression of transgene-encoded  IgM or 
IgD on bone marrow cells from Ig-transgenic mice. 
Bone marrow cells from MD-4,  MM-7,  and DD-6 
Ig-transgenic mice were stained with fluoresceinated 
antibody to B220 and biotinylated antibody recog- 
nizing either IgM, (/eft) or IgD" (right) followed by 
streptavidin/PE.  Rectangular  windows  ddineating 
B220 l~  (immature) and B220hlg  h (mature) B cells ex- 
pressing IgM" or IgD" were set by reference to equiva- 
lently stained and analyzed C57BL/6  nontransgenic 
bone marrow calls. 
Counterstaining of spleen cells  from MM and DD  Ig- 
transgenic  mice  for  HEL-binding  sites  revealed that  the 
majority  of IgH ~+ cells bound HEL in proportion  to their 
surface level of transgene-encoded H chain (Fig. 3). Since MD 
Ig-transgenic mice require expression of both L and H chain 
transgenes to produce high-affinity HEL.specific Ig (32), the 
antigen receptor phenotype of these "on-diagonal"  B cells 
demonstrated that they expressed transgenic g chain as their 
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Figure  3.  Expression  of  trans- 
gene-encoded  and  endogenous  Ig 
and  CD5  on  spleen  cells  from 
nontransgenic  and  MM  and  DD 
Ig-transgenic  mice.  Spleen  cells 
from  MM-4  Ig-transgenic  (lg.Tg) 
mice,  as  well  as  nontransgeuic 
(non-Tg)  C57BL/6  (B6;  IgHb+), 
CBA  (IgH,+),  and  (C57BL/6  x 
CBA)F1  mice  were  stained  with 
fluoresceinated  antibody  to  lgM ~ 
(left), and DD-6 Ig-transgenic and 
nontransgeuic  spleen  cells  were 
stained  with  fluoresceinated  anti- 
body  to  IgD'  (right).  Ceils  were 
counterstained  with  biotinylated 
antibodies  detecting  either  HED 
binding  (top),  IgM b (middle),  or 
CD5  (bottom)  followed by  strep- 
tavidin/PE.  In the top panels,  on- 
diagonal  Ig-transgenic B  cells ex- 
pressing proportional levels of IgH  ￿9 
and HEL-binding sites are indicated 
within the top windows. 
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and DD Ig-transgenic mice therefore appeared  to express 
transgene-encoded HEL-spedfic Ig as their sole species of an- 
tigen receptor. Moreover, the titration curves for binding of 
fluoresceinated HEL to MM and DD Ig-transgenic B cells 
were identical (Fig. 4), indicating that the transgene-encoded 
IgM and IgD antigen receptors expressed by these cells had 
an equivalent  affinity for HEL. In addition to on-diagonal 
B cells, MM and DD Ig-transgenic mice also contained low 
numbers of IgH  a+ cells which bound less than proportional 
amounts of HEL (Figs. 3 and 8), presumably because of ex- 
pression of either endogenously encoded L chains or of trans- 
genes with somatically mutated V region sequences. 
In both MM and DD Ig-transgenic mice, the majority of 
splenic IgH  '+  B cells did not appear to belong to the B1 
(Ly-1/CD5) lineage (13, 14) since they did not express CD5 
(Fig. 3) and displayed high levels of B220 characteristic  of 
mature conventional B cells (Fig. 9 A) (11, 13). Moreover, 
radiation chimeras that were produced by injecting nontrans- 
genic mice with adult bone marrow (which lacks B1 lineage 
precursors; 51) from MM and DD Ig-transgenic donors were 
efficiently  reconstituted with  IgH  '+  B  cells (Fig.  9  A). 
These findings were consistent with previous analyses of MD 
Ig-transgenic mice (45, 52), but contrasted with the preferen- 
tial development of B1 lineage cells described in some lines 
of Ig-transgenic mice (53). 
The pattern of expression of IgM by MM Ig-transgenic 
mice was very similar to that reported previously for MD 
Ig-transgenic mice (32, 45). Thus transgene-encoded  IgM  ' 
was present  at high levels on immature B2201~  h B 
lineage cells in bone marrow from MM as well as MD Ig- 
transgenic mice (Figs. 2 and 9 B), which is consistent with 
rapid expression of the already rearranged Ig transgenes during 
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Figure 4.  Titration of HEL-binding by MM-7 and DD-6 Ig-transgenic 
spleen cells. Equal numbers of spleen cells from MM-7 and DD-6 Ig- 
transgenic mice were combined, stained with various concentrations of 
HEL/fluorescein, and binding to IgM  =+  or IgD  =+  B cells resolved by 
counterstaining with specific biotinylated antibodies followed by strep- 
tavidin/PE. Mean green fluorescence of on-diagonal B cell populations 
(see Fig. 3) was measured and expressed as a percentage of the value ob- 
tained for cells stained with saturating (1,000 ng/ml) HEL/fluorescein. 
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the Pre-B cell stage of B lymphopoiesis (11, 45, 54). In addi- 
tion, constitutive secretion of anti-HEL IgM  ~ occurred in 
both types of unimmunized Ig-transgenic mice, with serum 
concentrations ranging from 2 to 50 #g/ml (Fig. 7 A). In 
DD Ig-transgenic mice, however, the pattern of IgD expres- 
sion differed from that seen in MD Ig-transgenics  and ap- 
peared more typical of the pattern usually associated with 
IgM. First, in contrast to MD Ig-transgenic and nontrans- 
genic mice in which surface expression of IgD was confined 
to mature B220~gh,HSA  l~  B cells (Figs. 2 and 9 B) (11, 45), 
IgD was also expressed on immature B22(~,HSA ~gh B cells 
in the bone marrow of DD Ig-transgenic mice (Figs. 2 and 
9 B).  Second,  whereas <0.1  #g/ml of secreted anti-HEL 
IgD  ' could be detected in the serum of MD Ig-transgenic 
mice (data not shown), levels of up to 100 #g/ml were con- 
stitutively present in DD Ig-transgenic sera (Fig. 7 A), and 
up  to  1,000 #g/ml could be elicited  in adoptive  transfer 
recipients of DD Ig-transgenic spleen cells challenged with 
HEL in immunogenic form (Fig. 6A). The observation in DD 
Ig-transgenic mice of both an early onset of/~ chain expres- 
sion in pre-B/immature B cells and a persistence of IgD ex- 
pression in Ig-secreting plasma cells is consistent with previous 
data from/~ chain transgenic mice (50), and presumably reflects 
the absence of the C# region in the V,10-/~ gene construct 
since transcription of C8 is normally prevented at both these 
stages of B cell differentiation  by termination immediately 
3' to C# (55,  56). 
Development and  Distribution of B  Cells in  Ig-transgenic 
Mice.  Since coexpression of IgM and IgD is characteristic 
of normal B cell development, it was interesting to see if the 
enforced expression of only one class of Ig would reveal any 
phase of development that was absolutely reliant on the pres- 
ence of either IgM or IgD. FACS  ~ analyses  of lymphoid tissues 
from MM and DD Ig-transgenic mice indicated that B cells 
expressing either IgM or IgD alone could mature into con- 
ventional B220~gh,HSA  l~  B cells with the capacity to popu- 
late peripheral lymphoid tissues and to circulate back to the 
bone marrow (Figs. 2, 3, and 9). Expression of ~ chain/IgD 
from the pre-B cell stage in DD Ig-transgenic mice therefore 
sustained the early development of B lineage cells within the 
bone marrow, a process which, under normal circumstances, 
relies on expression of functional # chain/IgM (57). Moreover, 
the maturation of surface Ig § B cells, including their migra- 
tion to peripheral lymphoid tissues and circulation back to 
the bone marrow, did not appear to depend on specific ex- 
pression of either IgM or IgD. 
The pattern of surface IgM and IgD expression not only 
varies during normal B cell maturation, but also differs be- 
tween B cells occupying physically distinct compartments 
within peripheral lymphoid tissues. In particular, B cell areas 
in the white pulp of the spleen can be resolved histologically 
into the follicular mantle zone, where B cells normally exhibit 
an IgMl~  h surface phenotype, and the surrounding 
marginal zone in which the B  cells are characteristically 
IgMhigh,IgD  I~  (12, 45). To establish whether development 
of these distinct subpopulations  of B cells depends on ex- 
pression of either IgM or IgD, spleens from MM and DD 
Ig-transgenic mice were examined  immunohistologically. Staining  revealed  that  cells  expressing  transgene-encoded 
IgH  ~ (Fig.  5,  A-D)  and exhibiting  HEI~binding  activity 
(Fig. 5, E and F) were readily identifiable in both the mantle 
and marginal zones of IgM-only and IgD-only transgenic 
spleens. Taken together, therefore, these results argue against 
an absolute requirement for either IgM or IgD in the devel- 
opment of B cells, or in their localization to the B cell microen- 
vironments within peripheral  lymphoid tissues. 
Antigenic Stimulation of B  Cells Expressing IgM or IgD 
Alone.  The observation that B cells expressing IgM or IgD 
alone developed and populated peripheral lymphoid tissues 
raised the question whether B cells expressing one or other 
class of antigen receptor could also be activated by antigen. 
Initially, the function of MM and DD Ig-transgenic B cells 
was assessed by measuring their T  cell-dependent antibody 
responses to HEL in vivo. To obviate the low responder status 
of C57BL/6 mice to HEL, it was necessary to challenge the 
B cells with HEL coupled to an immunogenic carrier and 
to provide a source of T  cell help (32).  For this purpose an 
adoptive transfer system was employed in which small numbers 
of Ig-transgenic spleen cells were transferred into irradiated 
nontransgenic recipients together with HEL coupled to the 
foreign carrier  SRBC  (HEL-SRBC)  and  spleen cells from 
SRBC-primed nontransgenic mice. Transgene-encoded anti- 
body production in recipient mice was subsequently mea- 
sured by serum ELISA for anti-HEL IgMa (MD  and MM 
Ig-transgenic donors) or anti-HEL IgD' (DD Ig-transgenic 
donors). As shown in Fig. 6 A, B calls from MM and DD, 
as well as MD  Ig-transgenic mice all generated substantial 
HEI.-specific antibody responses in the adoptive recipients 7 d 
after challenge with HEI.-SRBC. By contrast, immunization 
with uncoupled SRBC elicited 100-fold lower antibody re- 
sponses, demonstrating that the responses to HEL-SRBC were 
primarily dependent on specific binding of the SRBC car- 
ried by the antigen receptors of the HEbspecific B calls.  In 
addition, 10-fold-less  antibody was produced if carrier-primed 
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Figure 6.  Respomiveness  oflgM-only and IgD-only 
B cells to antigen in immunogenic form. C  A) T cell 
dependent antibody  responses  of Ig-transgenic  B cells. 
Spleen cells from MD-4, MM-7, and DD-6 Ig-trans- 
genie mice were transferred into irradiated nontrans- 
genie recipients, with  or  without  carrier primed 
(SRBC') spleen  cells, and challenged  with HEI.,coupled 
carrier (HELSRBC) or carrier alone (SRBC). (Dots) 
Serum levels of anti-HEL antibody as determined  by 
ELISA in individual recipients 7 d after transfer and 
challenge. Recipients  of nontransgenic  C57BL/6  donor 
spleen cells exhibited  undetectable  levels (<15 ng/ml) 
of both anti-HEL IgM  a and anti-HEL  IgD  =. (/3) Aug- 
mentation by HEL of in vitro proliferative  responses 
of Ig-transgenic  B cells to LPS. Spleen cells from non- 
transgenic C57BL/6 (non-Tg)  and MD-4, MM-7, and 
DD-6 Ig-transgenic  mice were stimulated with LPS 
•  HEL in vitro and pulsed with [3H]thymidine. 
(Dots) Radioactivity  incorporated  in individual  cultures. 
Increases in mean proliferation observed in cultures 
stimulated  with LPS + HEL relative to those stimu- 
lated with LPS alone  were: 153% (MD.4), 120% (MM- 
7), 380% (DD-6), and 4.5% (non-Tg). 
Figure 5.  Localization  of transgene-expressing  B cells in spleens from MM and DD Ig-transgenic  mice and double-transgenic  mice expressing soluble 
HEL. Frozen sections of spleens from MM-7 (A and C), MM-4 (E), and DD-6 (B, D, and F) Ig-transgenic  mice as well as MM-4 x  ML-5 (G) and 
DD-6  x  ML-5 (H) double-transgenic  mice were stained to reveal expression of IgM  = (.4 and C), IgD' (B and D), or HEL-binding  (E-H) using bi- 
otinylated antibodies and either avidin/alkaline  phosphatase (.4, C, and E-H) or avidin/horseradish  peroxidase (B and/9). Stained sections were pho- 
tographed at x 10 (.4 and B), x 100 (C and/9), or x 40 (E-H). Examphs of the marginal zones (mr), mantle zones (ran), and T call areas (t) of lymphoid 
follicles are indicated. Note the absence of marginal zone staining in the spleens from double-transgenic mice (G and H). 
997  Brink et al. spleen cells were omitted from the transfer inoculum, which 
is consistent with the T  cell dependence  of these antibody 
responses. 
According to previous data, signaling through the antigen 
receptors of MD Ig-transgenic B cells after binding of soluble 
HE[, in culture synergizes with the T cell independent prolifer- 
ative stimulus provided by LPS (46). To examine the relative 
abilities of IgM and IgD to provide a comitogenic signal for 
LPS-induced activation  of B ceils, MM and DD,  as well as 
MD  Ig-transgenic  spleen ceils, were cultured  with LPS in 
the presence or absence of soluble HEL (Fig. 6 B). Augmen- 
tation  of LPS-induced  proliferation by HEL was again ob- 
served in each case, indicating that antigenic signaling through 
either  IgM or IgD can synergize with LPS in inducing T 
cell independent  B  cell proliferation. 
Induction of Tolerance  in B Cells Expressing IgM or IgD Alone 
Previous experiments involving Ig-transgenic  models of self- 
tolerance in the B cell repertoire have demonstrated unrespon- 
siveness in autoreactive B cells because of both donal dele- 
tion and clonal anergy (32, 37, 58-60). In the anti-HEL Ig- 
transgenic model, B ceils specific for autologous cell mem- 
brane HEL are diminated from peripheral lymphoid tissues, 
whereas those recognizing the same self-antigen  in soluble 
form persist in a functionally silent (anergic) state character- 
ized by downregulation of surface IgM (32). Although both 
anergy and ddetion operate on IgM + B cells irrespective of 
the presence of surface IgD (32, 37, 44, 60), the ability of 
the IgD antigen receptor  to mediate  these forms of B cell 
tolerance remains unknown. To resolve this issue,  we have 
compared the development and function of DD Ig-transgenic 
B cells with those of MD and MM B cells in mice expressing 
HEL as either  a soluble or cell surface self-antigen. 
In the first set of experiments,  double-transgenic offspring 
were produced by mating the three types of Ig-transgenic 
mice with the transgenic  line MI~5,  mice from which ex- 
press HEL in soluble form at concentrations suf~cient to in- 
duce allergy in MD Ig-transgenic  B cells (32). When in situ 
levels of constitutively secreted anti-HEL IgH' were mea- 
sured in MM and DD double-transgenic mice and their Ig- 
transgenic littermate  controls,  reductions in antibody levels 
comparable with those observed for the MD double-transgenic 
combination were found (Fig. 7 A). Since immune complex 
formation has been formally  excluded previously  as a pos- 
sible explanation for the low antibody levels observed in the 
sera of double-transgenic mice (32, 44), these results are con- 
sistent with induction of tolerance in the B cells from all three 
double-transgenic combinations. 
The mechanism responsible  for self-tolerance in the MM 
x  ML-5 and DD  x  Mb5 double-transgenic mice proved 
to be similar to that operating in the original MD  x  Mb5 
double-transgenic combination,  according  to a number of 
functional and phenotypic criteria. First, autoreactive B cells 
were not deleted.  Rather, mature on-diagonal HEL-binding 
B cells persisted, albeit at reduced frequencies, in the spleen, 
lymph nodes, and bone marrow of both MM and DD double- 
transgenic  animals  (Fig.  8  and Table 1,  data not  shown). 
Second, antigen receptor levels were reduced on the surface 
of HEbbinding B cells derived from all three double-transgenic 
combinations.  As shown previously (32), receptor downregu- 
lation on MD double-transgenic B cells was confined to IgM 
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Figure  7.  Functional silencing of 
anti-HEL B cells in double transgenic 
mice expressing soluble HEL. (A) De- 
creased levels of transgene-encoded  anti- 
HEL  antibody in  sera from unim- 
munized double-transgenic (xMbS) 
mice (Dbl-Tg) relative to Ig-transgenic 
littermates (Ig-Tg). Antibody levels were 
measured by ELISA and were below 
the limits of detection (<20 ng/ml for 
anti-HEL IgM= and <30  ng/ml  for 
anti-HEL IgD =) in both nontransgenic 
and HEL-transgenic  sera. (B) Decreased 
responsiveness of  spleen cells from 
double-transgenic (xMI,5) relative to 
Ig-transgenic mice after adoptive trans- 
fer into  irradiated nontransgenic re- 
cipients together with HEI.,SRBC and 
SRBC' spleen cells. Anti-HEL antibody 
responses in recipients of Ig-transgenic 
and double-transgenic cells were mea- 
sured as for Fig. 6 A. The percentages 
of HEL-binding B cells in the donor 
spleen cell popuhtions were: MD-4 lg- 
Tg,  27.6%; MD-4  Dbl-Tg, 26.7%; 
MM-4 Ig-Tg, 10.4%; MM-4 Dbl-Tg, 
12.0%; DD-6 Ig-Tg, 12.5%; and DD-6 
Dbl-Tg, 10,2%. 
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Figure 8.  Reduced  expression of 
surface Ig  on  spleen cells from 
double-transgenic mice expressing 
soluble HEL. Spleen cells from Ig- 
transgenic  mice  and  double- 
transgenic (￿  MI,5) littermates  were 
stained with fluoresceinated anti- 
bodies to IgM' (/eft) or IgD' (right) 
and counterstained with HEL fol- 
lowed  by  HyHELS/biotin  and 
streptavidin/PE. 
(Fig.  8  and  Table  1).  Reduced  expression  of IgM was also 
observed on HEbbinding B cells from MM double-transgenic 
mice, although  the magnitude of downregulation  appeared 
slightly less (10-40-fold compared with 20-100-fold in MD 
transgenic animals; Fig. 8 and Table 1). Downregulation  of 
IgD expression  did  occur  on HEL-binding  cells from DD 
double-transgenic mice although this was limited to between 
a  two-  and fivefold reduction  (Fig.  8  and Table  1).  Third, 
the B cells from MM and DD, as well as MD double-transgenic 
mice proved to be intrinsically  anergic.  This was formally 
Table  1.  Splenic B  Cell Frequency and Antigen Receptor Downregulation in Double-transgenic Mice Expressing Soluble HEL 
Receptor 
B220 § cells  HEL-binding cells  downregulation 
Ig-Tg line  Tg genotype  %  No.  ( ￿  10 -6)  %  No.  ( ￿  10 -6)  IgM  *  IgD" 
MD-4  (n = 4)  Ig-Tg  55.5  47.7  49.2  42.3 
Dbl-Tg  42.7  37.9  37.2  33.0 
MM-4  (n = 1)  Ig-Tg  34.3  22.6  26.0  17.2 
Dbl-Tg  18.5  12.0  13.7  8.9 
MM-7  (n = 3)  Ig-Tg  31.4  17.8  26.2  14.8 
Dbl-Tg  20.8  9.4  12.7  5.8 
DD-1  (n = 2)  Ig-Tg  28.8  21.8  20.0  15.0 
Dbl-Tg  24.2  16.5  19.1  13.0 
DD-6  (n = 6)  Ig-Tg  29.7  14.8  17.4  8.7 
Dbl-Tg  18.4  9.1  9.4  4.6 
-  Non-Tg  60.0  70.0  0.2  0.2 





Spleen cells from littermate pairs of Ig-transgenic (Ig-Tg) and double-transgenic (Dbl-Tg) ( x  ML-5) mice were stained for HEL-binding sites, coun- 
terstained for IgM*, IgD', or B220, and analysed by FACS  |  Percentages of B220 + and HEL-binding cells were derived from FACS* plots and 
numbers per spleen calculated using the total number of nucleated cells recovered from each spleen. Values displayed represent means of data from 
n pairs of mice. For MM and DD mice, HEL-binding cells represent those in the on-diagonal population (see Fig. 3). Antigen receptor downregula- 
tion was estimated for each simultaneously analyzed pair by dividing mean IgM  * or lgD', fluorescence of double-transgenic HEL-binding cells by 
that of Ig-transgenic HEL-binding cells. The inverse of the mean of data obtained from n pairs of mice was used to give the degree of downregulation. 
Data for nontransgenic mice represent mean values obtained from four C57BL/6  mice. 
999  Brink et al. demonstrated  by transferring the cells out of their tolerant 
environment into irradiated recipients and stimulating them 
with HEL-SRBC in the presence of SRBC-primed T hdper 
cells.  10-100-fold less HEL-specific antibody was produced 
in recipients of MM and DD double-transgenic B ceils than 
in recipients of cells from nontolerant Ig-transgenic  controls 
(Fig.  7 B), thereby confirming that the self-reactive B cells 
expressing IgM or IgD alone were functionally silenced by 
soluble HEL. Finally, tolerant HEL-binding B ceils from MM 
and DD double-transgenic mice populated the follicular mantle 
zones in the spleen normally, but were absent from the splenic 
marginal zones (Fig. 5, G-H) as was found previously in MD 
double-transgenic animals (45). The reductions in splenic B 
cell numbers observed  in double-transgenic relative to Ig- 
transgenic mice (Table 1) are presumably due, at least in part, 
to depletion of marginal  zone HEl--binding B cells. 
These experiments established that signaling through IgD 
as well as IgM could induce clonal anergy in self-reactive B 
cells  after  exposure  to  soluble  self-antigen.  To  determine 
whether donal deletion could also be mediated by both classes 
of antigen receptor, a different HEDtransgenic line (KLK-3) 
was used in which HEL is expressed on the surface of a number 
of cell types, including bone marrow and peripheral lympho- 
cytes (37). To avoid the technical complication of membrane 
HEL expression by HEL-specific B cells, tolerance was exam- 
ined in a series of bone marrow chimeras rather than double- 
transgenic mice per se. For this purpose, bone marrow cells 
from each of the three types of Ig-transgenic  mice were used 
to reconstitute  lethally irradiated KLK-3  membrane HEL- 
transgenic, or nontransgenic mice. 6-wk later, spleen and bone 
marrow cells from the chimeric mice were subjected to FACS  | 
analysis. As expected, the spleens from nontransgenic recipients 
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Figure 9.  Clonal deletion  of anti-HEL 
IgM-only or IgD-only B cells in radiation 
chimeras  expressing  membrane-bound 
HEL.  Lethally  irradiated nontransgenic 
C57BL/6 mice (non-Tg) or KLK-3 trans- 
genic mice  expressing  ceU  surface HEL 
(KLK-3 HEI.,Tg) were reconstituted with 
bone marrow cells from MD-4, MM-7, or 
DD-6 Ig-transgenic donors. Spleen cells (.4) 
and  bone  marrow  cells  (B)  from  the 
chimeras were analyzed 6 wk after recon- 
stitution. Cells were stained for B220 with 
RA3-6B2/PE,  for  HSA  with  Mb69/ 
biotin followed by streptavidin/RED613, 
and for either IgM, with RS-3.1/fluores- 
cein  (left) or  for  IgD  = with AMS-15.t/ 
fluorescein (right). (A) In the spleen, very 
few IgM  "+ or IgD  '+ B cells remained in 
the KLK3 HEL-transgenic recipients. The 
B220 +,  IgH=-  cells  remaining  were 
shown in parallel stains to express IgML 
Fewer spleen cells were recovered from all 
KLK3 HEbtransgenic relative to nontrans- 
genic recipients,  the respective numbers 
(xl0 -6) being: 61 vs.  119 (MD-4 donor), 
53 vs. 100 (MM-7), and 40 vs. 67 (DD-6). 
(/3) In the bone marrow, mature (HSAIo*) 
B cells expressing IgM' or IgD" were also 
absent in KLK3 HEbtransgenic recipients. 
By contrast,  immature (HSA~g  h) B cells 
expressing  IgM= or  IgD"  persisted  but 
with reduced levels of surface Ig. of each type of Ig-transgenic bone marrow contained large 
numbers of B cells expressing the transgenic antigen receptor 
(IgH  ')  (Fig.  9 A).  By contrast,  KLK-3  membrane HEL- 
transgenic  recipients  contained very few IgH  ~+ B cells in 
their peripheral lymphoid tissues (Fig. 9 A), the B220 + cells 
that did persist  consisting mainly of those expressing en- 
dogenously encoded IgM  b (data not shown). This effect oc- 
curred in recipients of bone marrow not only from MD and 
MM Ig-transgenic donors (37), but also in those given DD 
Ig-transgenic cells. Moreover, as was reported previously for 
MD and MM chimeras (37), depletion of transgene-expressing 
B cells from the periphery of the membrane HEL expressing 
DD chimeras was only partially reflected in the bone marrow 
of these mice. Thus, although there was complete depletion 
of mature HSAl~  ~  + B cells in the bone marrow, the 
frequencies of immature HSAhigh,IgD  '+ B cells were not re- 
duced in KLK-3 compared with nontransgenic recipients (Fig. 
9 B). Since the mature B220high,HSA  l~  B cells of the bone 
marrow appear to represent cells that have recirculated from 
the periphery (11), the results from these chimeras suggest 
that  despite  encountering HEL  in  the bone marrow (as 
reflected in their reduced levels of antigen receptor;  Fig. 9 
B), the majority of transgene-expressing  B cells generated 
in membrane HEbbearing mice die in transit between the 
bone marrow and peripheral lymphoid tissues. Irrespective 
of the precise mechanism of peripheral  depletion of HEI~ 
binding B cells, these results clearly indicate that both IgM 
and IgD antigen receptors can mediate this process after rec- 
ognition of membrane-bound self-antigen. 
Discussion 
Transgenic mice with B cells expressing IgM or IgD as 
their sole species of surface Ig constitute a useful system for 
exploring the relative capabilities of these classes of antigen 
receptor in regulating B cell development and in mediating 
specific responses to antigen. In this report, IgM-only (MM) 
and IgD-only (DD) transgenic mice were produced in which 
the  majority of B  cells lacked  surface expression  of en- 
dogenously encoded Ig (Fig. 3) and bound HEL through their 
transgene-encoded IgM or IgD with homogeneous and iden- 
tical affinity (Fig. 4). Thus it was possible to compare the 
function of the two classes of antigen receptor during normal 
B cell development and upon exposure to foreign or self an- 
tigen in vivo. 
As has been found previously (48-50), expression of produc- 
tively rearranged/x or ~ transgenes in developing B lineage 
cells facilitated exclusion of endogenous Ig H chain expres- 
sion (Fig. 3) and promoted maturation of pre-B cells into 
immature B cells (Figs. 2 and 9 B). Although the signaling 
events involved in triggering these  steps in normal B cell 
differentiation remain unclear, these findings demonstrate that 
S-membrane H  chain can substitute for the #  chain trans- 
membrane region which is normally required to mediate these 
functions (48, 57). Similarly, no absolute requirement for IgM 
or IgD expression was found in the later stages orB cell matu- 
ration and migration since HEL-binding  B cells populated 
the spleens and lymph nodes of IgM-only and IgD-only Ig- 
transgenic mice and were found in both the mantle and mar- 
ginal zones of the spleen (Fig. 5). It is nevertheless difficult 
to exclude the existence of quantitative  differences between 
IgM and IgD in supporting B cell development.  Consistent 
with such a difference was the presence of fewer B cells in 
the spleens of IgM-only and IgD-only transgenic mice com- 
pared with IgM  +  IgD transgenic  animals (Figs. 8 and 9 
A, and Table 1) suggesting that expression of both IgM and 
IgD is required for B cell development to operate at optimal 
efficiency. On the other hand, B cells unable to produce/~ 
chain as a result of specific gene targeting appear to mature 
normally (61) suggesting that the maturation of B calls can 
operate optimally in the complete absence of IgD expression. 
The capacity of B ceils expressing only anti-HEL IgM or 
only anti-HEL IgD to mature in a similar fashion allowed 
these cells to be compared directly in terms of their reactivity 
to antigen during T cell dependent and T cell independent 
responses. Antigen binding to either surface IgM and IgD 
was capable of augmenting T cell independent B cell prolifer- 
ation in the presence of LPS (Fig. 6 B), which is consistent 
with previous findings  since dextran-conjugated anti-# or 
anti-$ antibodies are both efficient  T cell independent mitogens 
for B ceils (26). In addition, both IgM-only and IgD-only 
Ig-transgenic splenic B cells responded well to HEbcoupled 
SRBC in adoptive transfer (Fig. 6 A). These responses were 
primarily T cell dependent since 10-fold less antibody was 
produced in the absence of SRBC-primed spleen cells (Fig. 
6 A), although it is difficult to know to what extent they 
were dependent on cognate T-B cell interactions,  or on T 
cell independent type II activation rendering the B cells respon- 
sive to T cell-derived cytokines (62). The responsiveness of 
both IgM-only and IgD-only B ceils is nevertheless consis- 
tent  with previous  evidence that  these  classes of antigen 
receptor are indistinguishable  in their ability to internalize 
antigen for processing and presentation to T helper cells (25), 
Although more anti-HEL antibody was usually produced 
by IgD-only than by IgM-only B ceils in adoptive transfer, 
the specific IgM responses of IgM +  IgD B calls were essen- 
tially comparable with those of B cells from IgM-only mice 
(Figs. 6 A and 7 B). In other words, the production of higher 
levels of antibody by IgD-only compared with IgM-only B 
cells cannot be explained in terms of a more active role for 
IgD than IgM in mediating T cell dependent antibody re- 
sponses. Rather, it is more likely that the production and 
secretion of IgD antibody per se is more efficient than that 
of IgM, perhaps because of the different splicing events re- 
quired to produce secreted/~ and/~ chains (9), or to the addi- 
tional steps involved in the production of the secreted IgM 
pentamer. 
In contrast to B cell activation,  where signaling through 
membrane Ig must often be accompanied by other signals, 
induction orB cell tolerance appears to be mediated primarily, 
if not solely, via membrane Ig signaling (17, 63). In the ex- 
periments reported here, two distinct mechanisms of toler- 
ance shown previously to operate for IgM +  IgD transgenic 
B cells were both found to be triggered efficiently through 
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binding B cells were deleted from the peripheral lymphoid 
tissues of transgenic mice expressing HEL as an integral mem- 
brane protein (Fig. 9). Second, when B cells expressing ei- 
ther class of antigen receptor alone developed in transgenic 
mice expressing HEL in soluble form, they matured to popu- 
late the mantle zones of peripheral lymphoid follicles, but 
were in each case rendered anergic  and excluded from the 
follicular marginal zones (Figs. 5 and 7). Based on the differen- 
tial induction of deletion and anergy by multivalent membrane- 
bound HEL versus oligovalent/monovalent  soluble HEL, we 
have  previously suggested that  two  distinct  Ig-signaling 
thresholds may govern which of these processes is employed 
to induce B cell self-tolerance (37). The finding here that IgM 
and IgD appear equivalent in mediating deletion and anergy 
suggests that any differential signaling based on the degree 
of receptor crosslinkage is manifest through either class of 
antigen receptor. 
The observation that IgM and IgD can function inter- 
changeably in many of the in vivo events involved in B cell 
development is consistent with much of the previous evidence 
for the functional equivalence of these two classes of antigen 
receptor. These findings are also consistent with current struc- 
tural data on membrane Ig, since both IgM and IgD are known 
to be noncovalently associated with the CD3-1ike MB-1 (Ig-ol) 
and B29 (Ig-~) molecules (64, 65) which are believed to pro- 
vide the links between B cell antigen receptors and intracel- 
lular signaling pathways (66). It is difficult, however, to recon- 
cile  the efficient  induction of B  cell  anergy and deletion 
through either IgM or IgD with previous findings that nega- 
tive signaling in certain B cell lymphomas is specifically as- 
sociated  with  crosslinkage  of IgM but  not  IgD  antigen 
receptors (18, 19). Although in vitro growth inhibition of 
B lymphoma cells by anti-Ig antibody may involve signaling 
mechanisms distinct  from those responsible for  antigen- 
induced B cell tolerance in vivo, it is also possible that quan- 
titative signaling differences between IgM and IgD may not 
have been detected in the in vivo assays of B cell tolerance 
used here. This may apply particularly in the case of clonal 
deletion since  recent data  suggest that  deletion of IgM- 
expressing B cells by membrane-bound  HEL is equal/y effaeient 
when the affinity of the antigen receptor for HEL is over 
100-fold lower than in the experiments described here (S. B. 
Hartley & C. C. Goodnow, unpublished observations).  On 
the other hand, the level of soluble HEL used here to induce 
anergy in vivo is only just sufficient for tolerance induction 
(44), suggesting that quantitative differences of less than 10- 
fold in the signaling efficiency of IgD versus IgM would be 
readily detectable.  One intriguing explanation for the dis- 
crepancy in IgD function between these two models of B 
cell tolerance may lie in the fact that IgM was coexpressed 
with IgD on the surface of each of the B lymphoma lines 
examined (18, 19), whereas HElbspecific B cells from the IgD- 
only transgenic mice expressed IgD in the absence of IgM. 
The implication that IgD antigen receptor function may be 
significantly  modified by coexpression  of membrane IgM 
should be readily testable in the anti-HEL Ig-transgenic system. 
Overall,  only one consistent difference in the behavior of 
IgM and IgD antigen receptors was observed in the experi- 
ments described here. Thus, in B cells rendered anergic by 
autologous soluble HEL, the degree of antigen receptor down- 
regulation accompanying tolerance induction (Fig. 8 and Table 
1) was invariably greater for IgM (10-100-fold) than for IgD 
(less than twofold in IgM +  IgD mice and two- to five-fold 
in IgD-only mice). Since receptor downregulation on anergic 
B cells is not accompanied by reductions in the steady state 
levels of mlLNA encoding/~ or ~ membrane H chains (67, 
lk. Brink, unpublished observations), the changes in surface 
Ig expression and differences in the magnitudes of IgM and 
IgD downregulation must reflect translational or posttrans- 
lational events within the cells. Whatever the precise molec- 
ular explanation of downregulation, the observation of greater 
decreases in antigen receptor levels on IgM-only compared 
with IgD-only anergic B cells confirms that the original ob- 
servation of preferential IgM downregulation on IgM +  IgD 
anergic B cells (32) represents  a class-specific difference be- 
tween IgM and IgD which is not dependent on the coex- 
pression of IgD with IgM, nor on the expression  of IgD 
late in B cell maturation. The significance of this relative re- 
sistance of IgD to downregulation on anergic B cells neverthe- 
less remains unclear. 
The finding that IgM and IgD appear to be functionally 
interchangeable in vivo makes the role of IgD all the more 
perplexing. On the one hand, it must be considered possible 
that IgD performs no unique function and is instead either 
redundant or evolutionally obsolete. On the other hand, the 
IgD intron/exon organization and expression pattern are so 
distinctive (9) that it seems unlikely to have evolved without 
selection. Presumably unequivocal identification of a unique 
role  for  IgD  will  require  more detailed investigation of 
processes not examined in this report such as the generation 
and affinity maturation of memory B cells (15), or the modu- 
lation of antibody responses by T helper cells expressing IgD- 
binding molecules (68). These possibilities  are all amenable 
to further exploration using either the Ig-transgenic approach 
employed here, or IgD-deficient mice generated by gene tar- 
geting (61). 
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